FYI: Biotech shares outperformed the overall U.S. market by a wide margin in 2014, with the Nasdaq Biotechnology Index rising nearly 35%, versus 13.69% for the S&P 500® Index. That trend continued in the first quarter of 2015, when the biotech index rose 13% while the S&P 500® Index gained a mere 0.95%.
Can biotech maintain its momentum? Or is this a bubble waiting to burst?
Regards,
Ted
https://www.fidelity.com/viewpoints/investing-ideas/biotech-stocks
Comments
In any event, your deleted comment posited the notion that your posts are meant to stimulate thinking, which I'm sure you think is the case. Sadly, for the most part, they stimulate about as much thinking as anything Kramer has to say (again: imo,). A majority of them -- notice the moron did not say all of them -- are simply about button pushing and generating an immediate emotional response from the reader. David's monthly commentaries, by contrast, do generate thought and are well worth reading. Night n day.
Now, if you'll excuse me, I have to slap on my helmet and get back to work, under supervision, of course, as befits someone whose IQ is clearly just about the same as his age, if not less.
Regards,
Ted